RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 51.9719

Change

-50.66 (-49.36)%

Market Cap

N/A

Volume

3.39K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-07 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+2.09 (+6.13%)

USD 11.50B
QLD ProShares Ultra QQQ

+3.37 (+3.15%)

USD 7.34B
FNGU MicroSectors FANG+ Index 3X Le..

+34.87 (+7.14%)

USD 5.90B
SSO ProShares Ultra S&P500

+1.45 (+1.53%)

USD 5.40B
UPRO ProShares UltraPro S&P500

+2.08 (+2.25%)

USD 4.05B
TECL Direxion Daily Technology Bull..

+5.11 (+5.44%)

USD 3.15B
YINN Direxion Daily FTSE China Bull..

+5.37 (+16.19%)

USD 2.02B
USD ProShares Ultra Semiconductors

-68.78 (-47.86%)

USD 1.31B
LABU Direxion Daily S&P Biotech Bul..

+2.37 (+1.69%)

USD 0.91B
DPST Direxion Daily Regional Banks ..

-17.19 (-11.13%)

USD 0.74B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
ASWA:XETRA European Green Deal UCITS.. 2.35 % 0.00 %

+0.07 (+0.99%)

USD 0.02B
VXM:CA First Asset Morningstar I.. 0.56 % 0.70 %

+0.35 (+0.99%)

CAD 0.01B
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

+1.32 (+0.99%)

USD 0.10B
VXM-B:CA CI Morningstar Internatio.. 0.00 % 0.00 %

-0.36 (0.99%)

CAD 0.29B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

+1.11 (+0.99%)

USD 8.70B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

N/A

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

+0.76 (+0.99%)

USD 0.24B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

+0.91 (+0.99%)

USD 0.17B
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -92.89% 6% D- 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -92.89% 6% D- 1% F
Trailing 12 Months  
Capital Gain -91.64% 6% D- 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -91.64% 6% D- 1% F
Trailing 5 Years  
Capital Gain -88.09% 15% F 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -88.09% 15% F 3% F
Average Annual (5 Year Horizon)  
Capital Gain 13.27% 31% F 74% C
Dividend Return 13.50% 30% F 70% C-
Total Return 0.22% 22% F 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 30.23% 96% N/A 34% F
Risk Adjusted Return 44.64% 76% C+ 62% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.